Ameritas Investment Partners’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624K Buy
21,878
+5,654
+35% +$122K 0.02% 813
2026
Q1
$186K Hold
16,224
– – 0.01% 1307
2025
Q4
$233K Hold
16,224
– – 0.01% 1165
2025
Q3
$307K Sell
16,224
-2,481
-13% -$40.9K 0.01% 1008
2025
Q2
$401K Sell
18,705
-2,133
-10% -$31.7K 0.01% 937
2025
Q1
$273K Hold
20,838
– – 0.01% 1093
2024
Q4
$280K Buy
20,838
+1,141
+6% +$18.4K 0.01% 1134
2024
Q3
$418K Buy
19,697
+648
+3% +$11.7K 0.01% 908
2024
Q2
$301K Buy
19,049
+3,679
+24% +$67.6K 0.01% 1014
2024
Q1
$229K Hold
15,370
– – 0.01% 1198
2023
Q4
$141K Hold
15,370
– – 0.01% 1506
2023
Q3
$85.6K Buy
15,370
+2,596
+20% +$18.2K ﹤0.01% 1765
2023
Q2
$103K Buy
12,774
+3,914
+44% +$28.9K ﹤0.01% 1586
2023
Q1
$57.9K Hold
8,860
– – ﹤0.01% 1883
2022
Q4
$28K Hold
8,860
– – ﹤0.01% 2405
2022
Q3
$44K Hold
8,860
– – ﹤0.01% 2072
2022
Q2
$37K Buy
+8,860
New +$56.4K ﹤0.01% 2191

Other funds holding OSCR

Ameritas Investment Partners's OSCR Position: Q2 2026 in Review

Ameritas Investment Partners increased its Oscar Health (OSCR) stake by 35% in Q2 2026, buying an estimated $122K and bringing the position to 21,878 shares worth $624K. The position accounts for 0.02% of the portfolio, ranked #813.

Ameritas Investment Partners first reported a position in OSCR in Q2 2022 and has held it in 17 quarters since. 404 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Ameritas Investment Partners held 21,878 shares of Oscar Health worth $624K as of Q2 2026.
  • Ameritas Investment Partners bought 5,654 Oscar Health shares in Q2 2026, an estimated $122K.
  • Oscar Health made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #813 holding.
  • Ameritas Investment Partners first reported a position in Oscar Health in Q2 2022 and has held it in 17 quarters since.
  • 404 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.